View ValuationEagle Veterinary TechnologyLtd 将来の成長Future 基準チェック /06現在、 Eagle Veterinary TechnologyLtdの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長22.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Feb 20Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South Koreaお知らせ • Dec 25Eagle Veterinary Technology Co.,Ltd announced that it has received KRW 1.77621224 billion in fundingOn December 23, 2025. Eagle Veterinary Technology Co.,Ltd announces that it has closed the transaction.Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 09 April 2026. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (0.8%).Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₩10.5b (up 5.9% from 3Q 2024). Net income: ₩422.5m (up 128% from 3Q 2024). Profit margin: 4.0% (up from 1.9% in 3Q 2024). The increase in margin was driven by higher revenue.Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 9th April 2026 Dividend yield will be 1.5%, which is higher than the industry average of 1.1%. Sustainability & Growth The dividend has increased by an average of 14% per year over the past 3 years and payments have been stable during that time.お知らせ • Nov 07Eagle Veterinary Technology Co.,Ltd announces Annual dividend, payable on April 09, 2026Eagle Veterinary Technology Co.,Ltd announced Annual dividend of KRW 60.0000 per share payable on April 09, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.お知らせ • Feb 13Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South KoreaUpcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 17 April 2025. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (1.1%).分析記事 • Aug 12Here's Why Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per share at 0.7% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 17 April 2024. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.1%).New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Market cap is less than US$100m (₩86.6b market cap, or US$64.0m).Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩6,850, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 15x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 19% over the past three years.Valuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩7,070, the stock trades at a trailing P/E ratio of 33.8x. Average trailing P/E is 21x in the Pharmaceuticals industry in South Korea. Negligible returns to shareholders over past three years.Upcoming Dividend • Dec 21Inaugural dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 18 April 2023. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 1.0%.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩5,400, the stock trades at a trailing P/E ratio of 21.6x. Average trailing P/E is 19x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 25% over the past three years.Upcoming Dividend • Dec 22Inaugural dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 14 April 2022. The company is not currently making a profit but it is cash flow positive. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 0.8%.分析記事 • Apr 11Do Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...分析記事 • Mar 21Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Feb 23New 90-day low: ₩8,060The company is down 11% from its price of ₩9,010 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 4.0% over the same period.分析記事 • Feb 21Is Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Recent Price Movement Underpinned By Its Weak Fundamentals?It is hard to get excited after looking at Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) recent performance, when...Is New 90 Day High Low • Jan 29New 90-day low: ₩8,220The company is down 7.0% from its price of ₩8,800 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 14% over the same period.分析記事 • Jan 10Investors Who Bought Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Shares Three Years Ago Are Now Up 84%It might be of some concern to shareholders to see the Eagle Veterinary Technology Co.,Ltd ( KOSDAQ:044960 ) share...Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩9,370, the stock is trading at a trailing P/E ratio of 60.9x, down from the previous P/E ratio of 71.9x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 84%.分析記事 • Dec 20Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Has A Rock Solid Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 21% share price gain to ₩10,900, the stock is trading at a trailing P/E ratio of 70.9x, up from the previous P/E ratio of 58.6x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 103%.Is New 90 Day High Low • Dec 01New 90-day high: ₩10,200The company is up 9.0% from its price of ₩9,390 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 3.0% over the same period.分析記事 • Nov 23Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) stock is up by a considerable 11% over the past three months...Is New 90 Day High Low • Oct 12New 90-day high: ₩9,730The company is up 13% from its price of ₩8,620 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 13% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Eagle Veterinary TechnologyLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測KOSDAQ:A044960 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202643,6104,3343,1724,810N/A12/31/202543,3233,9463,9035,506N/A9/30/202542,5103,6865,0095,216N/A6/30/202541,9273,4496,1376,296N/A3/31/202541,8573,3143,5604,039N/A12/31/202441,7173,7052,5604,336N/A9/30/202441,5692,6651614,800N/A6/30/202442,0912,970-8545,081N/A3/31/202442,1922,896-3415,495N/A12/31/202342,7942,9763504,894N/A9/30/202343,1452,7663512,126N/A6/30/202343,1262,432419888N/A3/31/202343,8772,7621,5141,914N/A12/31/202243,5402,643-748-318N/A9/30/202244,0222,5621,4721,851N/A6/30/202242,9183,1592,6023,055N/A3/31/202241,4443,8143,6834,028N/A12/31/202140,4373,6385,8816,133N/A9/30/202139,5524,6175,8166,293N/A6/30/202140,4714,3905,1175,995N/A3/31/202140,7102,9664,6095,481N/A12/31/202040,3572,4595,0405,898N/A9/30/202039,0861,8875,2055,824N/A6/30/202037,2611,6186,3156,494N/A3/31/202035,7741,4894,6034,598N/A12/31/201934,4231,232N/A2,923N/A9/30/201932,9311,132N/A1,326N/A6/30/201931,518749N/A-858N/A3/31/201930,304924N/A1,891N/A12/31/201830,2621,042N/A2,021N/A9/30/201831,027892N/A1,773N/A6/30/201831,9011,272N/A3,510N/A3/31/201833,4801,544N/A1,164N/A12/31/201734,1561,555N/A512N/A9/30/201734,3693,347N/A2,730N/A6/30/201733,4253,039N/A2,043N/A3/31/201731,1462,581N/A2,800N/A12/31/201628,8462,234N/A3,128N/A9/30/201626,625483N/A1,011N/A6/30/201626,326745N/A678N/A3/31/201625,711852N/A206N/A12/31/201525,1051,034N/A-420N/A9/30/201524,2531,139N/A-610N/A6/30/201522,9891,214N/A331N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A044960の予測収益成長が 貯蓄率 ( 3.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: A044960の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: A044960の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: A044960の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: A044960の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A044960の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/06 02:05終値2026/06/05 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Eagle Veterinary Technology Co.,Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Feb 20Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 25, 2026, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South Korea
お知らせ • Dec 25Eagle Veterinary Technology Co.,Ltd announced that it has received KRW 1.77621224 billion in fundingOn December 23, 2025. Eagle Veterinary Technology Co.,Ltd announces that it has closed the transaction.
Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 09 April 2026. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (0.8%).
Reported Earnings • Nov 20Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₩10.5b (up 5.9% from 3Q 2024). Net income: ₩422.5m (up 128% from 3Q 2024). Profit margin: 4.0% (up from 1.9% in 3Q 2024). The increase in margin was driven by higher revenue.
Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 9th April 2026 Dividend yield will be 1.5%, which is higher than the industry average of 1.1%. Sustainability & Growth The dividend has increased by an average of 14% per year over the past 3 years and payments have been stable during that time.
お知らせ • Nov 07Eagle Veterinary Technology Co.,Ltd announces Annual dividend, payable on April 09, 2026Eagle Veterinary Technology Co.,Ltd announced Annual dividend of KRW 60.0000 per share payable on April 09, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
お知らせ • Feb 13Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025Eagle Veterinary Technology Co.,Ltd, Annual General Meeting, Mar 19, 2025, at 11:30 Tokyo Standard Time. Location: conference room, 235-34, chusa-ro, sinam-myeon, yesan-gun, chungcheongnam-do, South Korea
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 17 April 2025. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (1.1%).
分析記事 • Aug 12Here's Why Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per share at 0.7% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 17 April 2024. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.1%).
New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Market cap is less than US$100m (₩86.6b market cap, or US$64.0m).
Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩6,850, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 15x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 19% over the past three years.
Valuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 35%After last week's 35% share price gain to ₩7,070, the stock trades at a trailing P/E ratio of 33.8x. Average trailing P/E is 21x in the Pharmaceuticals industry in South Korea. Negligible returns to shareholders over past three years.
Upcoming Dividend • Dec 21Inaugural dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 18 April 2023. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 1.0%.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩5,400, the stock trades at a trailing P/E ratio of 21.6x. Average trailing P/E is 19x in the Pharmaceuticals industry in South Korea. Total loss to shareholders of 25% over the past three years.
Upcoming Dividend • Dec 22Inaugural dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 14 April 2022. The company is not currently making a profit but it is cash flow positive. This is the first dividend for Eagle Veterinary TechnologyLtd since going public. The average dividend yield among industry peers is 0.8%.
分析記事 • Apr 11Do Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
分析記事 • Mar 21Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Feb 23New 90-day low: ₩8,060The company is down 11% from its price of ₩9,010 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is down 4.0% over the same period.
分析記事 • Feb 21Is Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Recent Price Movement Underpinned By Its Weak Fundamentals?It is hard to get excited after looking at Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) recent performance, when...
Is New 90 Day High Low • Jan 29New 90-day low: ₩8,220The company is down 7.0% from its price of ₩8,800 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 14% over the same period.
分析記事 • Jan 10Investors Who Bought Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Shares Three Years Ago Are Now Up 84%It might be of some concern to shareholders to see the Eagle Veterinary Technology Co.,Ltd ( KOSDAQ:044960 ) share...
Valuation Update With 7 Day Price Move • Dec 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩9,370, the stock is trading at a trailing P/E ratio of 60.9x, down from the previous P/E ratio of 71.9x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 84%.
分析記事 • Dec 20Eagle Veterinary TechnologyLtd (KOSDAQ:044960) Has A Rock Solid Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 21% share price gain to ₩10,900, the stock is trading at a trailing P/E ratio of 70.9x, up from the previous P/E ratio of 58.6x. This compares to an average P/E of 30x in the Pharmaceuticals industry in South Korea. Total returns to shareholders over the past three years are 103%.
Is New 90 Day High Low • Dec 01New 90-day high: ₩10,200The company is up 9.0% from its price of ₩9,390 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 3.0% over the same period.
分析記事 • Nov 23Eagle Veterinary Technology Co.,Ltd's (KOSDAQ:044960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?Eagle Veterinary TechnologyLtd's (KOSDAQ:044960) stock is up by a considerable 11% over the past three months...
Is New 90 Day High Low • Oct 12New 90-day high: ₩9,730The company is up 13% from its price of ₩8,620 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 13% over the same period.